Healthcare booking platform DocPlanner raises €80M Series E led by One Peak Partners and Goldman Sachs Private Capital, bringing total raised to around €130M
Steve O'Hear / TechCrunch :
Context & Ripple Effects
DocPlanner's €15M Series D in 2017 made it one of Europe's better-funded medical booking startups, but the gap to its French rival was already visible: Doctolib had raised $42M that same year and was billed as one of the best-funded health startups on the continent. The €80M Series E, led by One Peak Partners and Goldman Sachs Private Capital, roughly doubles DocPlanner's total raised to around €130M and brings late-stage financial capital into a category previously funded by venture rounds.
The competitive frame matters: India's Practo raised $55M in 2017 explicitly to expand into more markets, showing that medical booking was already a multi-region land grab rather than a local software business.
First-order effects
- DocPlanner gains the war chest to defend and expand its Central and Southern European footprint against Doctolib, which operates the same doctor-side booking model in adjacent markets.
- Goldman Sachs Private Capital's lead marks a shift in DocPlanner's investor base from early-stage funds toward growth-stage capital, raising expectations of a path toward profitability or exit rather than another expansion experiment.
Second-order effects
- Doctolib's answer was to escalate: its later €500M equity-and-debt round at a €5.8B valuation shows the arms race this Series E fed into, with each player's raise pressuring the other to secure larger reserves.
- Clinics and doctors' practices become the contested customer: as platforms compete on subsidized scheduling tools and patient acquisition, switching costs and exclusivity terms tighten for the practices both sides are courting.
Third-order effects
- Booking platforms alone look under-defensible over time — Berlin's Patient21 later raised a €100M Series C by pairing its digital platform with brick-and-mortar clinics, suggesting the endgame is owning care delivery, not just the calendar.
- If the pattern holds, each region converges on one or two heavily capitalized booking incumbents backed increasingly by non-traditional investors like private capital arms, squeezing out sub-scale national players.
The trend: Healthcare appointment booking is consolidating into a capital-intensive regional-winner game, with late-stage and non-traditional investors replacing seed-era funds as the category matures.